vVARDIS
vVARDIS offers innovative biomimetic dental products under the CURODONT brand, designed to treat early-stage decay and promote tooth enamel remineralization.
vVARDIS has 1 recorded funding round in the Tech.eu database (amounts undisclosed). Based in Zug, Switzerland; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€0
€0
Funding rounds
1
Investors
1
distinct backers
Active since
2026-04
latest 2026-04
Funding by year
EUR raised per year · 2026 YTDvVARDIS — funding by year — interactive chart.
Data table
| vVARDIS — funding by year | |
|---|---|
| 2026 | €0 |
Signals
Medium confidenceRaise-next likelihood25
base rate 30% for Other
- ▼ Raised very recently
- ▼ Low backer re-investment
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-04-28 | Other | — | Apollo-managed funds | View deal → |
Investors
1Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData